Latest

Apr 12, 2016
Pharmaceutical Executive
The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements.
Apr 06, 2016
William Looney speaks with DIA's Global Chief Executive to see how the organization is repositioning itself.
Apr 04, 2016
Despite all the research as to the safety and benefits of immunization, the anti-vaccine film "Vaxxed: From Cover-Up to Catastrophe” could convince millions that vaccines are unsafe, writes Jill Wechsler.
Apr 03, 2016
LEO Pharma CEO Gitte Aabo talks to PE about issues pertinent to dermatology.
Apr 01, 2016
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last month, it was difficult to be pessimistic, writes Bill Drummy.
Apr 01, 2016
Peter Young examines the drivers affecting the biotech industry in 2015, and what to expect in 2016.
Mar 24, 2016
Novartis's Panos Papakonstantinou says pharma still needs to perfect its approach to multi-channel marketing.
Mar 24, 2016
Several factors are combining to change the definition of what healthcare truly is, and how it will be delivered and experienced in the next few years.
Mar 23, 2016
Just as insurers and regulators have sought to tamp down compounding costs and utilization, observers are acknowledging that the practice may be an antidote to spiraling drug prices. John S. Linehan reports.
Mar 18, 2016
Pharm Exec talks value-based healthcare with Professor Bengt Jönsson of the Stockholm School of Economics.
native1_300x100
lorem ipsum